Insulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination.

Regulation of hormonal, insulin/IGF-1 (Ins/IGF-1) signaling activities, and pathways of the intrinsic generation of reactive oxygen species (ROS) play a role in aging and longevity determination. In this review we discuss the cross-talk between these pathways as mechanisms of signaling that may be important factors in the regulation of aging and longevity. The balance of physiological processes controlling the rate of aging and longevity in several mouse mutants suggests the involvement of cross-talk mechanisms of regulation of the insulin/IGF1 signaling pathway vs. the ROS signaling pathways. In mice, modulation of the Ins/IGF-1 signaling pathways resulting from the Prop1(df), Pit1(dw) and Igf1 receptor mutations exemplify the hormonal pathways associated with aging and longevity determination. These pathways are also targets of the ROS-mediated redox pathways. Similarly, the Klotho and p66(Shc) mutants link regulation of ROS signaling pathways to aging and longevity determination. Both of these models also display altered insulin signaling activity, a characteristic associated with longevity. The Ins/IGF-1 signaling pathway is of particular interest because of its decreased activity due to genetic manipulation vs. its responsiveness to ROS levels.